Skip to content
★ Sign in to follow
RH
Total declarations
11
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€325k

Latest filing published 30 Dec 2015 for Neogenomics INC, €35k.

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

No signal scores available.

Robert H. Horel: trading record in brief

All filings by Robert H. Horel on record concern Neogenomics Inc. We count 11 filings; the first trade dates from 18 December 2014 and the latest from 29 December 2015.

On the market, this insider has only sold: 2 sales, €325k in total. The rest of the record consists of 9 option exercises.

The newest entry dates from 30 December 2015: an option exercise of €35k, in Neogenomics Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Robert H. Horel

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total
  • ◇
    Vice President GM PathLogicExecutivesNeogenomics Inc
    38,016 USD0SEC
    26,218 shares@ US$1.45Common StockSEC:0001209191-15-087391:0
  • ◇
    Vice President GM PathLogicExecutivesNeogenomics Inc
    42,250 USD0SEC
    25,000 shares@ US$1.69Common StockSEC:0001209191-15-087391:1
  • ◇
    Vice President andGM PathLogicExecutivesNeogenomics Inc
    6,037 USD0SEC
    4,107 shares@ US$1.47Common StockSEC:0001144204-14-075351:0
  • ◇
    Vice President andGM PathLogicExecutivesNeogenomics Inc
    2,480 USD0SEC
    4,000 shares@ US$0.62Common StockSEC:0001144204-14-075351:1
  • ◇
    Vice President andGM PathLogicExecutivesNeogenomics Inc
    735 USD0SEC
    500 shares@ US$1.47Common StockSEC:0001144204-14-075351:2
  • ◇
    Vice President andGM PathLogicExecutivesNeogenomics Inc
    34,484 USD0SEC
    23,782 shares@ US$1.45Common StockSEC:0001144204-14-075351:3
  • ▼
    Vice President andGM PathLogicExecutivesNeogenomics Inc
    136,303 USD0SEC
    32,389 shares@ US$4.2083Common StockSEC:0001144204-14-075351:4
  • ◇
    Vice President andGM PathLogicExecutivesNeogenomics Inc
    26,303 USD0SEC
    17,893 shares@ US$1.47Common StockSEC:0001144204-14-075028:0
  • ◇
    Vice President andGM PathLogicExecutivesNeogenomics Inc
    7,050 USD0SEC
    5,000 shares@ US$1.41Common StockSEC:0001144204-14-075028:1
  • ◇
    Vice President andGM PathLogicExecutivesNeogenomics Inc
    57,200 USD0SEC
    40,000 shares@ US$1.43Common StockSEC:0001144204-14-075028:2
  • ▼
    Vice President andGM PathLogicExecutivesNeogenomics Inc
    264,151 USD0SEC
    62,893 shares@ US$4.20Common StockSEC:0001144204-14-075028:3

11 of 11 declarations